BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18311538)

  • 1. Nonfunctioning endocrine pancreatic tumor examined with 18F-FDG PET/CT.
    Toshikuni N; Kai K; Fujisawa M
    Ann Nucl Med; 2008 Feb; 22(2):133-7. PubMed ID: 18311538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors.
    Luo G; Liu Z; Guo M; Jin K; Xiao Z; Liu L; Xu J; Zhang B; Liu C; Huang D; Hu S; Ni Q; Long J; Yu X
    Int J Oncol; 2014 Oct; 45(4):1531-6. PubMed ID: 25096059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
    Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
    J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of a deep-inspiration breath-hold 18F-FDG PET/CT technique in diagnosing liver, bile duct, and pancreas tumors.
    Nagamachi S; Wakamatsu H; Kiyohara S; Fujita S; Futami S; Arita H; Nishii R; Tamura S; Kawai K
    Nucl Med Commun; 2009 May; 30(5):326-32. PubMed ID: 19282791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.
    Kitasato Y; Yasunaga M; Okuda K; Kinoshita H; Tanaka H; Okabe Y; Kawahara A; Kage M; Kaida H; Ishibashi M
    Pancreas; 2014 Oct; 43(7):1060-5. PubMed ID: 25121413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT.
    Epelbaum R; Frenkel A; Haddad R; Sikorski N; Strauss LG; Israel O; Dimitrakopoulou-Strauss A
    J Nucl Med; 2013 Jan; 54(1):12-8. PubMed ID: 23166388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collision of Solid Pseudopapillary Tumor and Neuroendocrine Tumor of the Pancreas on 18F-FDG PET/CT.
    Yin H; Lv J; Chen L; Xiu Y; Shi H
    Clin Nucl Med; 2021 Apr; 46(4):e214-e215. PubMed ID: 33208615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
    Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic involvement detected with (18)F-FDG PET/CT in disseminated sarcoidosis.
    Delgado-Bolton RC; Arias Navalón JA; Rodríguez Alfonso B; Delgado-Bolton AN; Pérez-Castejón MJ; Sánchez-Escribano R; Cabrera Martín MN; Lapeña Gutiérrez L; Carreras Delgado JL
    Rev Esp Med Nucl; 2011; 30(1):29-32. PubMed ID: 20638156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic usefulness of FDG-PET for malignant somatostatinoma of the pancreas.
    Suzuki H; Kuwano H; Masuda N; Hashimoto S; Kanoh K; Nomoto K; Shimura T; Katoh H
    Hepatogastroenterology; 2008; 55(85):1242-5. PubMed ID: 18795665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18 F-fluorodeoxyglucose positron emission tomography for characterization and initial staging of pancreatic tumors].
    Valinas R; Barrier A; Montravers F; Houry S; Talbot JN; Huguier M
    Gastroenterol Clin Biol; 2002 Oct; 26(10):888-92. PubMed ID: 12434099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlations with (18)FDG PET scan patterns in solid pseudopapillary tumors of the pancreas: still a surgical enigma?
    Kang CM; Cho A; Kim H; Chung YE; Hwang HK; Choi SH; Lee WJ
    Pancreatology; 2014; 14(6):515-23. PubMed ID: 25256437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of 18F-FDG PET/CT in an unusual case of solid-pseudopapillary pancreatic tumor in childhood with aggressive behavior.
    Treglia G; Caporale N; Rufini V; Callea F; Locatelli F; Giordano A
    Clin Nucl Med; 2013 Jan; 38(1):e35-7. PubMed ID: 23242062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET/CT in the evaluation of anal carcinoma.
    Cotter SE; Grigsby PW; Siegel BA; Dehdashti F; Malyapa RS; Fleshman JW; Birnbaum EH; Wang X; Abbey E; Tan B; Kodner IJ; Hunt SR; Lowney JK; Mutch MG; Dietz DW; Myerson RJ
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):720-5. PubMed ID: 16626889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ¹⁸F-FDG PET/CT imaging of the pancreas: spectrum of diseases.
    Nguyen VX; Nguyen CC; Nguyen BD
    JOP; 2011 Nov; 12(6):557-66. PubMed ID: 22072244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT/MRI.
    Ruf J; Lopez Hänninen E; Oettle H; Plotkin M; Pelzer U; Stroszczynski C; Felix R; Amthauer H
    Pancreatology; 2005; 5(2-3):266-72. PubMed ID: 15855825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.